DOI : 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Issue 01 · Volume 50 · January 2012 DOI: 10.1055/s-002-22742


28. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber
Hamburg, 27.–28. 1. 2012

Kongresspräsidentin: Prof. Dr. rer. nat. Gisa Tiegs

FV1_01
Roderfeld, M; Kampschulte, M; Langheinrich, A; Tschuschner, A; Kremer, S; Roeb, E: Artherosklerosemäuse (apoE-/- x LDLR-/-) entwickeln eine Leberfibrose mit HCC unter fettreicher Diät
FV1_02
Lange, N; Sieber, S; Erhardt, A; Sass, G; Kreienkamp, HJ; Tiegs, G: Essential role of Sharpin in TNFα dependent NFκB activation in primary hepatocytes
FV1_03
Hall, R; Heim, I; Huss, S; Alberts, R; Schughart, K; Hochrath, K; Weber, SN; Müllenbach, R; Williams, RW; Lammert, F: Identification of phenotypic and expression quantitative trait loci (p/eQTLs) affecting liver fibrosis by genome-wide association analysis in recombinant inbred mouse lines
P1_01
Arndt, S; Wacker, E; Saugspier, M; Dorn, C; Hellerbrand, C; Bosserhoff, A: BMP6 protects against hepatic inflammation and fibrosis in experimental NASH models
P1_02
Barikbin, R; Neureiter, D; Wirth, JW; Erhardt, A; Schwinge, D; Kluwe, J; Schramm, C; Tiegs, G; Sass, G: Induction of heme oxygenase 1 in Mdr2ko mice reduces hepatic inflammation, prevents fibrosis progression and supports fibrolysis
P1_04
Breitkopf-Heinlein, K; Li, Q; Goumans, MJ; Wiercinska, E; ten Dijke, P; Dooley, S: Neutralization of Bone Morphogenetic Protein (BMP)–9 in mouse liver reduces CCl–4 mediated fibrogenesis
P1_05
Cubero, FJ; Zhao, G; Hatting, M; Drvarov, O; Nevzorova, Y; Al Massoudi, M; Gassler, N; Liedtke, C; Trautwein, C: JNK1 is protective for the progression of NEMO-dependent hepatitis
P1_06
Czech, B; Valletta, D; Saugspier, M; Weiss, TS; Dorn, C; Bosserhoff, A; Hellerbrand, C: Increased expression of the glucose transporter GLUT1 in liver fibrosis
P1_07
Czech, B; Valletta, D; Saugspier, M; Dettmer, K; Stevens, A; Dorn, C; Weiss, TS; Bosserhoff, A; Oefner, P; Hellerbrand, C: Downregulation of methylthioadenosine phosphorylase (MTAP) expression in chronic liver disease promotes hepatic inflammation and fibrosis
P1_10
Dostert, K; Saugspier, M; Dorn, C; Hellerbrand, C; Gäbele, E: The Role of PI3K p110gamma in chronic liver injury
P1_11
Dostert, K; Dorn, C; Weiss, TS; Gäbele, E; Hellerbrand, C: Enhanced TLR4 expression in steatotic hepatocytes
P1_12
Godoy, P; Schmidt-Heck, W; Widera, A; Campos, G; Guthke, R; Gebhardt, R; Arrese, M; Dooley, S; Reif, R; Hengstler, JG: Cultivation of primary hepatocytes induces an inflammation-cholestasis response that resembles features of in vivo inflammation during damage and regeneration
P1_13
Granzow, M; Klein, S; Schierwagen, R; Linhart, M; Werner, N; Huss, S; Sauerbruch, T; Trebicka, J: Der AT1-Rezeptor reguliert die Expression der Renin-Angiotensin-Systen(RAS)-Komponenten in der Fibrose
P1_14
Granzow, M; Klein, S; Schierwagen, R; Kahrmann, K; Linhart, M; Huss, S; Werner, N; Sauerbruch, T; Trebicka, J: Rolle der Janus-Kinase 2 (Jak2) bei der AT1-Rezeptor-vermittelten hepatischen Fibrose
P1_15
Granzow, M; Klein, S; Granzow, R; Gautsch, S; Himmit, M; Huss, S; Sauerbruch, T; Trebicka, J: Renin-überexprimierende Ratten, ein genetisches Tiermodell zur spontanen Fibrose und portalen Hypertension
P1_17
P1_20
Huang, J; Elfimova, N; Noetel, A; Amer, W; Kwiecinski, M; Dienes, HP; Peter, H; Odenthal, M: TGF-beta mediates transcriptional repression of miR–29 a/b1 during liver fibrosis
P1_22
Klein, S; Granzow, M; Schierwagen, R; Huss, S; Van Beuge, M; Poelstra, K; Sauerbruch, T; Trebicka, J: HSC gezielte Hemmung der Rho-kinase senkt den Portaldruck mit geringen systemischen Nebenwirkungen
P1_23
Klein, S; Granzow, M; Schierwagen, R; Lalemann, W; Sauerbruch, T; Trebicka, J: Jak–2 Hemmung senkt den Pfortaderdruck bei der Leberzirrhose
P1_24
Klein, S; Granzow, M; Schierwagen, R; Huss, S; Körner, C; Weber, S; Fürst, D; Pieper-Fürst, U; Nattermann, J; Lammert, F; Trebicka, J; Sauerbruch, T: Atorvastatin vermindert die Proliferation und Apoptose in hepatischen Sternzellen durch die Seneszenz Induktion
P1_27
Liu, Y; Meyer, C; Ilkavets, I; Li, Q; Müller, A; Dooley, S; Weng, HL: Dll4 plays a critical role in HBV-associated liver fibrogenesis
P1_29
Lunova, M; Vaulont, S; Haybaeck, J; Lackner, K; Strnad, P: Hepcidin knockout mice as a model of iron-overload associated liver fibrosis development
P1_30
Mahli, A; Thasler, WE; Weiss, TS; Gäbele, E; Hellerbrand, C: Novel in vitro models of alcohol-mediated hepatic injury
P1_31
Marquardt, JU; Maass, T; Krupp, M; Staib, F; Gaiser, T; Andersen, JB; Galle, PR; Thorgeirsson, SS; Teufel, A: Mechanistic and therapeutic implications of PDGF-b activation during liver fibrogenesis
P1_32
Meurer, SK; Wimmer, AE; van de Leur, E; Weiskirchen, R: More than a serum parameter: Functional relevance of soluble endoglin (solEng)
P1_36
Müller, K; Güldiken, N; Kücükoglu, O; Chen, Y; Usachov, V; Kulaksiz, H; Strnad, P: TAA aber nicht CCl4 reduziert Hepcidin-Expression und führt zu einer Eisenüberladung in der Leber
P1_37
Nellen, A; Heinrichs, D; Moreno Zaldivar, M; Fischer, P; Berres, ML; Proudfoot, A; Trautwein, C; Wasmuth, HE: Inhibiting the oligomerisation and glycosaminoglycan binding of the chemokine CCL5 reduces experimental liver injury in vivo
P1_38
Nischalke, HD; Berger, C; Luda, C; Coenen, M; Krämer, B; Körner, C; Nattermann, J; Sauerbruch, T; Spengler, U: Das CXCL1 rs4074 A Allel führt nach TLR2 Stimulation zu einer verstärkten CXCL1 Expression und ist ein Risikofaktor für Zirrhose bei HCV Genotype 1-infizierten Patienten
P1_41
Pasupuleti, S; Koc, A; Batra, A; Siegmund, B; Kremer, S; Roderfeld, M; Roeb, E: Transfer colitis in Rag1-/-- mice enhances hepatic MMP–9 expression
P1_42
Pieper-Fürst, U; Hall, R; Hochrath, K; Tacke, F; Weiskirchen, R; Lammert, F: Evidence for a heterodimeric structure of megalin in liver macrophages
P1_43
Pinna, F; Tuncay, S; D'Alessandro, LA; Gauges, R; Bissinger, M; Klingmuller, U; Kummer, U; Schirmacher, P; Breuhahn, K: Dissection TNFα/NF-κB signalling in murine hepatocytes–a model for the priming phase of liver regeneration
P1_45
Sahin, H; Schmitz, P; Kiessling, F; Trautwein, C; Wasmuth, HE: The CXCR3 ligand CXCL9 attenuates neoangiogenesis and liver fibrosis in vivo
P1_51
Valletta, D; Czech, B; Saugspier, M; Dorn, C; Bosserhoff, A; Hellerbrand, C: Expression of the atypical cadherin Fat1 in hepatic fibrosis
P1_52
P1_55
P1_56
Wang, B; Bröring, R; Real, CI; Trippler, M; Gerken, G; Lu, M; Schlaak, JF: HCV/TLR3 modulated the expression of RANTES in murine activated hepatic stellate cells
P1_58
Weiskirchen, R; Weimer, J; Arnold, N; Xu, L; Friedman, SL; Bergmann, C: Genetic characteristics of the human hepatic stellate cell line LX–2
P1_59
Weng, H; Radaeva, S; Feng, D; Gao, Y; Liu, Y; Li, Q; Shen, H; Müllenbach, R; Huang, T; Chen, JL; Zimmer, V; Lammert, F; Mertens, PR; Zakhari, S; Cai, WM; Dooley, S; Gao, B: IFN-gamma inhibits hepatic progenitor cell activation in patients with chronic hepatitis B and in mice